These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7687554)

  • 21. Clinical, laboratorial, and urodynamic findings of prostatic artery embolization for the treatment of urinary retention related to benign prostatic hyperplasia. A prospective single-center pilot study.
    Antunes AA; Carnevale FC; da Motta Leal Filho JM; Yoshinaga EM; Cerri LM; Baroni RH; Marcelino AS; Cerri GG; Srougi M
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):978-86. PubMed ID: 23580116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of benign prostatic hyperplasia.
    Barry M; Roehrborn C
    Annu Rev Med; 1997; 48():177-89. PubMed ID: 9046954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Similarity of the American Urological Association Symptom Index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction.
    Chancellor MB; Rivas DA; Keeley FX; Lotfi MA; Gomella LG
    Br J Urol; 1994 Aug; 74(2):200-3. PubMed ID: 7522872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive assessment of prostatic obstruction in elderly men with lower urinary tract symptoms associated with benign prostatic hyperplasia.
    van Venrooij GE; Eckhardt MD; Boon TA
    Urology; 2004 Mar; 63(3):476-80. PubMed ID: 15028441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical prostatic protrusion can predict therapeutic response to silodosin in male patients with lower urinary tract symptoms.
    Matsukawa Y; Ishida S; Majima T; Funahashi Y; Sassa N; Kato M; Yoshino Y; Gotoh M
    Int J Urol; 2017 Jun; 24(6):454-459. PubMed ID: 28370376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prostatic middle lobe hyperplasia correlates with bladder outflow obstruction: analysis of 131 cases].
    Shen H; Zhou HT; Wu HF; Yu HB; Li BJ; Zhang B; Lin JZ
    Zhonghua Nan Ke Xue; 2011 Jun; 17(6):527-30. PubMed ID: 21735652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of invasive urodynamic testing in benign prostatic hyperplasia and male lower urinary tract symptoms.
    Mehdizadeh JL; Leach GE
    Urol Clin North Am; 2009 Nov; 36(4):431-41, v. PubMed ID: 19942043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlations of urodynamic changes with changes in symptoms and well-being after transurethral resection of the prostate.
    Van Venrooij GE; Van Melick HH; Eckhardt MD; Boon TA
    J Urol; 2002 Aug; 168(2):605-9. PubMed ID: 12131318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of American Urological Association symptom index with obstructive and nonobstructive prostatism.
    Yalla SV; Sullivan MP; Lecamwasam HS; DuBeau CE; Vickers MA; Cravalho EG
    J Urol; 1995 Mar; 153(3 Pt 1):674-9; discussion 679-80. PubMed ID: 7532231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urodynamic assessment and quantification of prostatic obstruction before and after transurethral resection of the prostate: standardization with the aid of the computer program CLIM.
    Rollema HJ; van Mastrigt R; Janknegt RA
    Urol Int; 1991; 47 Suppl 1():52-4. PubMed ID: 1719685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction.
    Thomas AW; Cannon A; Bartlett E; Ellis-Jones J; Abrams P
    J Urol; 2005 Nov; 174(5):1887-91. PubMed ID: 16217330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re: The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis.
    Haab F
    J Urol; 1997 Jun; 157(6):2266-7. PubMed ID: 9146649
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis of infravesical obstruction in patients with benign prostatic hyperplasia].
    Al'-Shukri SKh; Amdiĭ RE
    Urologiia; 2006; (2):41-3, 45. PubMed ID: 16708588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urodynamic Features and Significant Predictors of Bladder Outlet Obstruction in Patients With Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia and Small Prostate Volume.
    Kang M; Kim M; Choo MS; Paick JS; Oh SJ
    Urology; 2016 Mar; 89():96-102. PubMed ID: 26683755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
    Haab F
    Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment.
    Jiang YH; Wang CC; Kuo HC
    PLoS One; 2018; 13(2):e0190704. PubMed ID: 29462145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.